Prevention and management of antineoplastic therapy induced oral mucositis
- PMID: 22442583
- PMCID: PMC3304209
- DOI: 10.4103/0975-5950.79214
Prevention and management of antineoplastic therapy induced oral mucositis
Abstract
With the scientific advancements in the management of malignant diseases, the treatment is expensive and bears high morbidity in term of oral mucositis. It is a debilitating condition and has been researched extensively for its pathogenesis and treatment. Various treatment options include barrier forming, mucosal protectants, mouth rinses, growth factors, lasers and midline-sparing procedures. Some agents are used locally while others are administered systemically. Despite the availability of a wide range of treatment options for mucositis, a cost-effective treatment is yet to be evolved.
Keywords: Antineoplastic therapy; mucosal protectants; oral mucositis.
Conflict of interest statement
References
-
- Sonis ST. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34:39–43. - PubMed
-
- Knox JJ, Puodziunas AL, Feld R. Chemotherapy-induced oral mucositis: Prevention and management. Drugs Aging. 2000;17:257–67. - PubMed
-
- Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer. 1993;72:1612–7. - PubMed
-
- Sonis ST. A biological approach to mucositis. J Support Oncol. 2004;2:21–36. - PubMed
-
- Sonis ST. The Pathobiology of Mucositis. Nat Rev Cancer. 2004;4:277–84. - PubMed
